Xencor (XNCR) Revenue (2013 - 2026)

Xencor (XNCR) reported Revenue of $4.5 million for Q1 2026, down 86.2% year-over-year from $32.7 million in Q1 2025, and down 84.01% quarter-over-quarter from $28.2 million in Q4 2025.

Xencor (XNCR) Revenue (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Revenue data on file, last reported at $4.5 million in Q1 2026.

  • Revenue for Q1 2026 came in at $4.5 million, down 86.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $97.4 million (down 23.48% YoY), and the FY2025 annual result was $125.6 million, up 13.65% from the prior year.
  • Revenue eased to $4.5 million in Q1 2026 per XNCR's latest filing, from $28.2 million in the prior quarter.
  • Over five years, Revenue peaked at $85.5 million in Q1 2022 and troughed at $4.5 million in Q1 2026.
  • A 5-year average of $34.1 million and a median of $28.2 million in 2025 frame the typical range for Revenue.
  • The sharpest annual moves came in 2022 and 2026: Revenue jumped 151.46% in 2022, then sank 86.2% in 2026.
  • A 5-year view of Revenue shows it stood at $21.6 million in 2022, then surged by 136.18% to $51.0 million in 2023, then climbed by 3.49% to $52.8 million in 2024, then slumped by 46.51% to $28.2 million in 2025, then plunged by 84.01% to $4.5 million in 2026.
  • Business Quant data shows XNCR's Revenue at $4.5 million in Q1 2026, $28.2 million in Q4 2025, and $21.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 5.21 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 306.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.99 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Xencor 953.38 Mn 878.64 Mn - 4.52 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.52 Mn
Dec 31, 2025 28.24 Mn
Sep 30, 2025 21.00 Mn
Jun 30, 2025 43.61 Mn
Mar 31, 2025 32.73 Mn
Dec 31, 2024 52.79 Mn
Sep 30, 2024 17.80 Mn
Jun 30, 2024 23.91 Mn
Mar 31, 2024 16.00 Mn
Dec 31, 2023 51.02 Mn
Sep 30, 2023 59.16 Mn
Jun 30, 2023 45.52 Mn
Mar 31, 2023 18.96 Mn
Dec 31, 2022 21.60 Mn
Sep 30, 2022 27.30 Mn
Jun 30, 2022 30.20 Mn
Mar 31, 2022 85.50 Mn
Dec 31, 2021 154.02 Mn
Sep 30, 2021 19.68 Mn
Jun 30, 2021 67.45 Mn